Monte Carlo Calculation of Radioimmunotherapy with (90)Y-, (177)Lu-, (131)I-, (124)I-, and (188)Re-Nanoobjects: Choice of the Best Radionuclide for Solid Tumour Treatment by Using...

por Lucas, S., Feron, O., Gallez, B., Masereel, B., Michiels, C., Vander Borght, T.
Publicado 2015

PTEN deficiency is associated with reduced sensitivity to mTOR inhibitor in human bladder cancer through the unhampered feedback loop driving PI3K/Akt activation

por Seront, E, Pinto, A, Bouzin, C, Bertrand, L, Machiels, J-P, Feron, O
Publicado 2013

Tumour hypoxia determines the potential of combining mTOR and autophagy inhibitors to treat mammary tumours

por Seront, E, Boidot, R, Bouzin, C, Karroum, O, Jordan, B F, Gallez, B, Machiels, J-P, Feron, O
Publicado 2013

Cancer heterogeneity is not compatible with one unique cancer cell metabolic map

por Strickaert, A, Saiselet, M, Dom, G, De Deken, X, Dumont, J E, Feron, O, Sonveaux, P, Maenhaut, C
Publicado 2017

Gut microbiota-derived propionate reduces cancer cell proliferation in the liver

por Bindels, L B, Porporato, P, Dewulf, E M, Verrax, J, Neyrinck, A M, Martin, J C, Scott, K P, Buc Calderon, P, Feron, O, Muccioli, G G, Sonveaux, P, Cani, P D, Delzenne, N M
Publicado 2012